Medicure Inc (MCUJF)
MCUJF is quoted over the counter, not listed on an exchange. Medicure Inc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | MCUJF, quoted over the counter |
| SEC CIK | 0001133519 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Winnipeg |
| Incorporated in | MB |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-04-24 |
| Cash and burn | 3.8M CAD cash; operating cash flow -140K CAD a quarter. | Report 2025-12-31 |
| Shares outstanding | 10,436,313 (2025-12-31); 10,436,313 a year earlier; 10,251,313 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Ernst & Young LLP, Winnipeg, Canada | PCAOB Form AP 2026-05-08 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | 28.9M CAD | -7.1M CAD | -560K CAD | 3.8M CAD | No debt tags | 28.9M CAD | 20-F 2026-04-24 |
| FY 2024 2024-12-31 | 21.9M CAD | -1.0M CAD | 1.4M CAD | 7.2M CAD | No debt tags | 21.9M CAD | 20-F 2025-04-25 |
| FY 2023 2023-12-31 | 21.7M CAD | -922K CAD | 2.1M CAD | 6.4M CAD | No debt tags | 21.7M CAD | 20-F 2025-04-25 |
| FY 2022 2022-12-31 | 23.1M CAD | 1.4M CAD | 1.8M CAD | 4.9M CAD | No debt tags | 23.1M CAD | 20-F 2025-04-25 |
| FY 2021 2021-12-31 | 21.7M CAD | -727K CAD | 4.0M CAD | 3.7M CAD | No debt tags | 21.7M CAD | 20-F 2024-04-09 |
| FY 2020 2020-12-31 | 11.6M CAD | -6.8M CAD | -2.2M CAD | 2.7M CAD | No debt tags | 11.6M CAD | 20-F 2023-04-06 |
| FY 2019 2019-12-31 | 20.2M CAD | -19.8M CAD | -14.6M CAD | 13.0M CAD | No debt tags | 20.2M CAD | 20-F 2022-04-29 |
| FY 2018 2018-12-31 | 29.1M CAD | 3.9M CAD | 742K CAD | 24.1M CAD | No debt tags | 29.1M CAD | 20-F 2021-04-21 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CAD.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 20-F | 2026-04-24 |
| Latest quarterly / interim | 6-K | 2026-08-19 |
Source: SEC EDGAR submissions feed, 481 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier